Sequenom Shares Jump 62 Percent in Strong February for GWDN Index | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Sequenom rose 62 percent during the month of February — boosted by the launch of a couple of molecular diagnostic tests — to lead all of the 33 stocks in the GenomeWeb Daily News Index.

The San Diego-based firm was one of four stocks in the Index that gained more than 20 percent for the month. The others included Affymetrix (+38 percent), Millipore (+37 percent), and Caliper Life Sciences (+23 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.